[Fetal supraventricular tachycardia. Management].
We report two cases of fetal supraventricular tachycardia with hydrops fetalis. The transplacental therapy with digoxin, sotalol and amiodarone, using combination of both of this drugs, has given in one case a partial conversion, total in the second case. Ultrasounds allow diagnosis of SVT, evaluate the gravity when it is associated with fetal hydrops secondary to a congestive heart failure, research a cause and follow the evolution during the treatment. The treatment must begin when diagnosis of SVT is done, by digoxin; other drugs as sotalol, amiodarone or flecainide acetate are described and also direct fetal therapy by intramuscular or into the umbilical vein injections.
Amiel
C
C
Maternité Belle de Mai, Marseille.
Chau
C
C
Millet
V
V
Agher
J P
JP
Gamerre
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000638:Amiodarone / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005315:Fetal Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D015160:Hydrops Fetalis / Q000150:complications*; D011247:Pregnancy; D013617:Tachycardia, Supraventricular / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy; D016216:Ultrasonography, Prenatal
D000319:Adrenergic beta-Antagonists; D004077:Digoxin; D000638:Amiodarone
Tachycardies supraventriculaires foetales. Conduite à tenir.